By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
WALTHAM, Mass., Dec. 7 Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it has received approval by the State of New York's Department of Health for the Company to sell in New York its PST Genetic Test that determines predisposition ...
SEOUL, Korea, Dec. 6 RNL Bio Co., Ltd, (www.rnl.co.kr) a leading biopharmaceutical company specialized in adult stem cell therapeutics announced today that a 46-year-old female, Kang Sook Park's Multiple Sclerosis improved ...
Explore how semen cfDNA analysis revolutionizes male infertility diagnosis, offering a non-invasive, accurate method for identifying azoospermia and varicocele.
Geisinger's MyCode program identifies previously unknown health risks through genetic screening, facilitating early intervention and prevention.
AI identifies immune system changes that predict rheumatoid arthritis onset, leading to early prevention.
Suppressing the ZNF638 protein tricks the body into attacking glioblastoma , a potential breakthrough in brain cancer therapy.
Discover the newly identified proteins to predict ICANS, improving the safety of CAR-T cell therapy by identifying high-risk patients pre-treatment.
Subscribe to our Free Newsletters!